Development of the Composition and Technology of a New Dental Gel with Anti-Inflammatory and Antimicrobial Action
DOI:
https://doi.org/10.18321/ectj958Abstract
The development of a dental gel that meets modern requirements for the effectiveness and safety of a medicinal product is a serious scientific study related to the selection of active and auxiliary substances, providing the necessary biopharmaceutical and rheological properties of the gel composition, standardizing the quality of the dosage form. The article presents the results of a study on the development of the composition and technology of the soft dosage form of the new dental gel «Matripin- Dent» using pharmacologically active ingredients of the sum of flavonoids from Populus balsamifera L. buds (pinostrobin, pinocembrin, chrysin, techtochrysin) and the sum of terpenoids from Matricaria chamomilla L. (bisabolol oxides A and B, chamazulene). Three bases are selected: fat, gel, and multicomponent. According to the results of pharmacological studies, the optimal composition is a gel base containing polyethylene oxide 1500 and 400. The rheological index of the gel base confirms its thixotropic properties, good spreadability, the ability of the obtained gel to extrude from the tube, and stability. The indicators of control and critical points of the technological process are determined and a technological scheme for the production of dental gel is developed.
References
(1). J.I. Pattanshetti, I. Tiwari, G. Singh, F. Tazyeen, A.S. Parihar, N. Khare, Journal of International Oral Health 8 (2016) 296‒301.
(2). N.R. Shagalieva, V.A. Kurkin, E.V. Avdeeva, I.M. Baikirov, A.E. Scherbovskikh, Fundamental studies [Fundamental Research] 10 (2013) 1490–1494 (in Russ.).
(3). V.L. Bagirova, N.B. Demina, N.A. Kulichenko, Ointments. Modern view of the dosage form, Popular science journal “Farmatsiya” [Pharmacy] 2 (2002) 24‒26 (in Russ.).
(4). B. Rescala, W. Rosalem, R.P. Teles, R.G. Fischer, A.D. Haffajee, S.S. Socransky, A. Gustafsson, C.M. Figueredo, J. Periodontol. 81 (2010) 1308–1316. Crossref
(5). K. Bansal, M.K. Rawat, A. Jain, A. Rajput, T.P. Chaturvedi, S. Singh, AAPS PharmSciTech 10 (2009) 716‒723. Crossref
(6). S.K. Yellanki, J. Singh, F. Manvi, International Journal of Pharma and Bio Sciences 1 (2010) 1‒9.
(7). R. Patel, H. Patel, A. Baria, Int. J. Drug Deliv. Technol. 4 (2009) 42‒45. Crossref
(8). N. Sapna, K.L. Vandana, J. Investig. Clin. Dent. 2 (2011) 162‒170. Crossref
(9). V. Yakovenko, D. Orlenko, L. Vyshnevska, ScienceRise: Pharmaceutical Science 5 (2019) 35‒41. Crossref
(10). M.N.A. Rahman, O.A.J.A. Qader, S. Sukmasari, A.F. Ismail, A.A. Doolaanea, Journal of Pharmaceutical Sciences and Research 9 (2017) 2633–2640.
(11). C.M. Ofner, C.M. Klech-Gelotte, J. Swarbrick, J.C. Boylan (Eds.) (2002). Gels and jellies. Vol. 2. Encyclopedia of Pharmaceutical Technology. New York; Basel: Marcel Dekker, 1327–1344.
(12). S.M. Adekenov, A.N. Zhabayeva, Kh.I. Itzhanova, N.G. Titova, Protivoparadontoznoe sredstvo [Anti-periodontal drug]. Patent RK, no. 32653, 2018 (In Russ).
(13). A.N. Zhabayeva, N.G. Titova, Kh.I. Itzhanova, S.M. Adekenov, K.D. Altynbekov, 12th International Symposium on the Chemistry of Natural Compounds, Tashkent, 2017, p. 304.
(14). Z.D. Khadzhieva, Zilfikarov I.N., E.A. Teunova, Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya [Scientific statements of Belgorod State University. Series: Medicine. Pharmacy] 22 (2010) 58‒65 (In Russ.).
Downloads
Published
How to Cite
Issue
Section
License
You are free to: Share — copy and redistribute the material in any medium or format. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Eurasian Chemico-Technological Journal applies a Creative Commons Attribution 4.0 International License to articles and other works we publish.
Subject to the acceptance of the Article for publication in the Eurasian Chemico-Technological Journal, the Author(s) agrees to grant Eurasian Chemico-Technological Journal permission to publish the unpublished and original Article and all associated supplemental material under the Creative Commons Attribution 4.0 International license (CC BY 4.0).
Further distribution of this work must maintain attribution to the author(s) and the published article’s title, journal citation, and DOI.